Recency Bias Is Very Powerful Drug

Recency bias is a very powerful drug, and we feel bad for Americans who are FOMOing into the same worthless companies that worked for this past decade but won't work for this next decade. The best ETF for capitalizing on this new decade is NIA's #1 favorite ETF suggestion iShares MSCI Brazil ETF (EWZ).

Although we are very bullish on gold, we aren't fans of Vaneck Vectors Gold Miners ETF (GDX) because the largest gold miners operate like government bureaucracies and the brightest and best gold executives are actually running new start-up gold exploration companies that they plan to build into multi-billion-dollar gold companies, like they achieved multiple times in the past. Investing into these gold exploration companies at the ground-floor will easily achieve 10-50X larger returns than GDX.

EWZ will rise for exactly the same reasons as GDX and gold exploration stocks, but EWZ has much greater upside than GDX!

EWZ gained by 2.03% today to a new 2023 high of $33.69 per share and closed above its most important long-term key breakout point!

Past performance is not an indicator of future returns. NIA is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. This message is not a solicitation or recommendation to buy, sell, or hold securities. NIA's President owns a position in EWZ. This message is meant for informational and educational purposes only and does not provide investment advice.